Back to mobile site

More on ALLR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)

Upcoming Events

- Earnings (8/17/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Allarity Therapeutics (NQ:ALLR)
Delayed: 1.43 +0.09 (6.72%)
Prev. Close $1.34  
Open$1.35 
52 Wk High$ 
52 Wk Low$ 
Day High$1.48 
Day Low$1.28 
P/E N/A  
EPS$ 
Volume297,933 


Jun 18, 2026 08:00 AM Allarity to present stenoparib Phase 2 poster at ESMO congress
Jun 18, 2026 08:00 AM Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
Jun 2, 2026 05:11 PM Form 8-K Allarity Therapeutics, For: May 27
May 18, 2026 06:46 AM Allarity Therapeutics (ALLR) Misses Q1 EPS by 17c
May 15, 2026 04:30 PM Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
May 15, 2026 04:06 PM Form 10-Q Allarity Therapeutics, For: Mar 31
May 14, 2026 11:49 AM Form 4 Allarity Therapeutics, For: Jan 28 Filed by: Jensen Thomas
May 11, 2026 03:22 PM Form 4 Allarity Therapeutics, For: Jan 28 Filed by: Hoeiland Jesper
May 11, 2026 03:21 PM Form 3 Allarity Therapeutics, For: Jun 10 Filed by: Hoeiland Jesper
May 8, 2026 05:20 PM Form 8-K Allarity Therapeutics, For: May 08
View All Articles

Entities mentioned with ALLR

View All Entities